The Enterprise Value as of November 2025 (TTM) for Aurobindo Pharma Limited (AUROPHARMA.NS) is 678.49B

According to Aurobindo Pharma Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 678.49B. This represents a change of -8.37% compared to the average of 740.46B of the last 4 quarters.

Aurobindo Pharma Limited (AUROPHARMA.NS) Historical Enterprise Value (quarterly & annually)

How has AUROPHARMA.NS Enterprise Value performed in the past?

The mean historical Enterprise Value of Aurobindo Pharma Limited over the last ten years is 463.51B. The current 678.49B Enterprise Value has changed 14.54% with respect to the historical average. Over the past ten years (40 quarters), AUROPHARMA.NS's Enterprise Value was at its highest in in the September 2024 quarter at 868.69B. The Enterprise Value was at its lowest in in the March 2020 quarter at 277.52B.

Aurobindo Pharma Limited (AUROPHARMA.NS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Aurobindo Pharma Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aurobindo Pharma Limited (AUROPHARMA.NS) Average Enterprise Value

How has AUROPHARMA.NS Enterprise Value performed in the past?

The current Enterprise Value of Aurobindo Pharma Limited (AUROPHARMA.NS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Aurobindo Pharma Limited (AUROPHARMA.NS) Enterprise Value vs. Peers

How is AUROPHARMA.NS’s Enterprise Value compared to its peers?

Aurobindo Pharma Limited’s Enterprise Value is less than Alkem Laboratories Limited (681.10B), less than Alkem Laboratories Limited (681.10B), less than Lupin Limited (902.52B), greater than Laurus Labs Limited (532.11B), greater than Abbott India Limited (627.92B), less than Lupin Limited (902.52B), greater than Laurus Labs Limited (532.11B), greater than Abbott India Limited (627.92B), greater than Glenmark Pharmaceuticals Limited (512.84B), greater than Glenmark Pharmaceuticals Limited (512.84B),

Build a custom stock screener for Aurobindo Pharma Limited (AUROPHARMA.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aurobindo Pharma Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aurobindo Pharma Limited (AUROPHARMA.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aurobindo Pharma Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.